These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26874164)

  • 1. Visual function alterations in Alzheimer Disease: A case report.
    Pablo Piñero D; Monllor B; Moncho V; de Fez D
    Can J Ophthalmol; 2016 Feb; 51(1):e16-8. PubMed ID: 26874164
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and therapeutic challenges.
    Janáky M; Braunitzer G; Benedek G; Vörös E; Kocsis BP; Clamp MF; Fu AD
    Retina; 2014 Feb; 34(2):408-13. PubMed ID: 24169099
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of acquired color vision deficiency in glaucoma using the Rabin cone contrast test.
    Niwa Y; Muraki S; Naito F; Minamikawa T; Ohji M
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6686-90. PubMed ID: 25168899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond visual acuity: new and complementary tests of visual function.
    Trick GL
    Neurol Clin; 2003 May; 21(2):363-86. PubMed ID: 12916484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vision in Alzheimer's disease: a focus on the anterior afferent pathway.
    Pelak VS; Hills W
    Neurodegener Dis Manag; 2018 Feb; 8(1):49-67. PubMed ID: 29359625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dysfunction of the magnocellular pathway in Alzheimer's disease].
    Jacob B; Hache JC; Pasquier F
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):555-64. PubMed ID: 12072823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral domain optical coherence tomography findings in long-term silicone oil-related visual loss.
    Shalchi Z; Mahroo OA; Shunmugam M; Mohamed M; Sullivan PM; Williamson TH
    Retina; 2015 Mar; 35(3):555-63. PubMed ID: 25127046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.
    Ekici F; Loh R; Waisbourd M; Sun Y; Martinez P; Nayak N; Wizov SS; Hegarty S; Hark LA; Spaeth GL
    JAMA Ophthalmol; 2015 Dec; 133(12):1377-85. PubMed ID: 26425961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired dyschromatopsia in acute myelocytic leukaemia.
    Ziaei M; Holder GE; Elgohary MA; Bremner FD
    Doc Ophthalmol; 2013 Dec; 127(3):249-53. PubMed ID: 24052224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical color vision testing and correlation with visual function.
    Zhao J; Davé SB; Wang J; Subramanian PS
    Am J Ophthalmol; 2015 Sep; 160(3):547-552.e1. PubMed ID: 26116263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal cohort study of patients with birdshot chorioretinopathy. IV. Visual field results at baseline.
    Gordon LK; Monnet D; Holland GN; Brézin AP; Yu F; Levinson RD
    Am J Ophthalmol; 2007 Dec; 144(6):829-837. PubMed ID: 17937923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Persistant bilateral relative central scotomas induced by taking an excessive dose of sildenafil'.
    Izadi S; De Silva SR; Sculfor D; Benjamin L; Downes SM
    Acta Ophthalmol; 2012 Sep; 90(6):e496-8. PubMed ID: 22928790
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of Hardy-Rand-Rittler and Ishihara colour plates for the diagnosis of nonglaucomatous optic neuropathy.
    Aroichane M; Pieramici DJ; Miller NR; Vitale S
    Can J Ophthalmol; 1996 Dec; 31(7):350-5. PubMed ID: 8971455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Color vision tests and visual evoked potentials in multiple sclerosis].
    Pinckers AJ; Verriest G; Cruysberg JR
    Ophtalmologie; 1987; 1(1):45-8. PubMed ID: 3153816
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual signs and symptoms in patients with the visual variant of Alzheimer disease.
    Kaeser PF; Ghika J; Borruat FX
    BMC Ophthalmol; 2015 Jun; 15():65. PubMed ID: 26122482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmologic manifestations of Alzheimer's disease.
    Katz B; Rimmer S
    Surv Ophthalmol; 1989; 34(1):31-43. PubMed ID: 2678551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal achromatic and chromatic contrast sensitivity in neurofibromatosis type 1.
    Ribeiro MJ; Violante IR; Bernardino I; Ramos F; Saraiva J; Reviriego P; Upadhyaya M; Silva ED; Castelo-Branco M
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):287-93. PubMed ID: 22190595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blue-on-yellow perimetry in tobacco and alcohol consumers].
    de Carvalho JF; Danda D; Dantas H; Arraes TA; Cavalcanti E
    Arq Bras Oftalmol; 2006; 69(5):675-8. PubMed ID: 17187133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
    Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.